EC

EcoR1 Capital Portfolio holdings

AUM $2.19B
1-Year Est. Return 120.56%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+120.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.08B
AUM Growth
+$396M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$53.8M
2
+$29.4M
3
+$20.2M
4
MBX
MBX Biosciences
MBX
+$13M
5
AQST icon
Aquestive Therapeutics
AQST
+$11.3M

Top Sells

1
+$197M
2
+$107M
3
+$34M
4
KURA icon
Kura Oncology
KURA
+$23.7M
5
AKRO
Akero Therapeutics
AKRO
+$23.5M

Sector Composition

1 Healthcare 99.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEPG icon
26
PepGen
PEPG
$428M
$3.7M 0.18%
+800,000
NUVB.WS
27
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$3.56M 0.17%
963,333
VYGR icon
28
Voyager Therapeutics
VYGR
$228M
$3.13M 0.15%
670,303
-3,247,243
CMPS
29
Compass Pathways
CMPS
$783M
$1.52M 0.07%
+265,137
SRZNW icon
30
Surrozen Inc Warrant
SRZNW
$63.6K
$859K 0.04%
66,665
ADAP
31
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-27,404,070
AKRO
32
DELISTED
Akero Therapeutics
AKRO
– –
-440,000
DAWN icon
33
Day One Biopharmaceuticals
DAWN
$1.09B
– –
-862,068
HLVX
34
DELISTED
HilleVax
HLVX
– –
-2,420,243
ITOS
35
DELISTED
iTeos Therapeutics
ITOS
– –
-10,688,978
JANX icon
36
Janux Therapeutics
JANX
$819M
– –
-1,469,818
MGNX icon
37
MacroGenics
MGNX
$126M
– –
-1,602,717
PCRX icon
38
Pacira BioSciences
PCRX
$901M
– –
-457,471
REPL icon
39
Replimune Group
REPL
$632M
– –
-850,341
VRNA
40
DELISTED
Verona Pharma
VRNA
– –
-200,000
TECX
41
Tectonic Therapeutic
TECX
$439M
– –
-935,121
WHWK
42
Whitehawk Therapeutics
WHWK
$165M
– –
-1,091,417
1
2